Jessica Newcomb sold $199K of Tango Therapeutics stock
By AlphaYouPublished Form 4
Newcomb Jessica
Reporting filer
Jessica Newcomb reported selling 8,200 shares of Tango Therapeutics, Inc. for about $199K ($24.22 a share on average). Form 4 filed Sep 24, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Sep 24, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Newcomb Jessica | 2026-09-22 | S | Sale | 700 | 22.8029 | 66,621 | 2 days | Filed terms
|
| Common Stock | Newcomb Jessica | 2026-09-22 | S | Sale | 5100 | 23.9683 | 61,521 | 2 days | Filed terms
|
| Common Stock | Newcomb Jessica | 2026-09-22 | S | Sale | 2400 | 25.1718 | 59,121 | 2 days | Filed terms
|
Common Stock
- Owner
- Newcomb Jessica
- Date
- 2026-09-22
- Code
- S
- Action
- Sale
- Quantity
- 700
- Price
- 22.8029
- Following holdings
- 66,621
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 700
- transaction Price Per Share: 22.8029
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 66621
- id: F3
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Newcomb Jessica
- Date
- 2026-09-22
- Code
- S
- Action
- Sale
- Quantity
- 5100
- Price
- 23.9683
- Following holdings
- 61,521
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 5100
- transaction Price Per Share: 23.9683
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 61521
- id: F3
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Newcomb Jessica
- Date
- 2026-09-22
- Code
- S
- Action
- Sale
- Quantity
- 2400
- Price
- 25.1718
- Following holdings
- 59,121
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 2400
- transaction Price Per Share: 25.1718
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 59121
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Newcomb Jessica: Principal Accounting Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 23, 2026.
- F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.37 to $23.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F3: The amount reported in Column 2 includes 43,666 unvested restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.52 to $24.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.59 to $25.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Original sources
Prepared automatically from public filing data. Report a correction.